Pharmaceutical Investing Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
Pharmaceutical Investing Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
Medical Device Investing Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
Freegold Reports Final 2024 Drilling Results from Golden Summit Continuing to Confirm Higher Grade Potential
Group Eleven Intersects 12.0m of 2.30% Cu and 560 g/t Ag, Including 6.4m of 3.72% Cu and 838 g/t Ag, Demonstrating High-Grade Copper and Silver Potential at Ballywire
